4 products were found matching "LKT-S0006.%25"!
No results were found for the filter!
Cabozantinib
Item number: LKT-C0006.25
Cabozantinib or XL-184 is a tyrosine kinase (c-MET, VEGFR2) inhibitor. It has been shown to reduce tumor growth, metastasis, angiogenesis, and induce apoptosis.
| Keywords: | XL-184, BMS-907351, N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| CAS | 849217-68-1 |
| MW: | 501.51 D |
From 121.00€
*
Dacomitinib (hydrate)
Item number: LKT-D0006.25
A potent, irreversible pan-ErbB inhibitor, mostly to EGFR with IC50 of 6 nM, effective against NSCLCs with EGFR or ERBB2 mutations (resistant to gefitinib) as well as those harboring the EGFR T790M mutation.
| Keywords: | PF-00299804 |
| Application: | erbB / EGFR inhibitor |
| CAS | 1042385-75-0 |
| MW: | 488 D |
From 149.00€
*
LY-2606368
Item number: LKT-L960006.25
CHK1 inhibitor.
| Keywords: | LY 2606368, LY2606368, Prexasertib |
| Application: | CHK1 inhibitor |
| CAS | 1234015-52-1 |
| MW: | 365.4 D |
From 180.00€
*
SR144528
Item number: LKT-S680000.25
Selective cannabinoid receptor 2 (CB2) inverse agonist.
| Keywords: | 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1R,3S,4S)-2,2,4-trimethyl-3-bicyclo[2.2.1]heptanyl]pyrazole-3-c... |
| Application: | CB2 antagonist |
| CAS | 192703-06-3 |
| MW: | 476.06 D |
From 161.00€
*
